| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $406.6M | -2.0% | +13.5% |
| Cost of Revenue | $74.7M | -10.6% | +11.2% |
| Gross Profit | $331.9M | +0.2% | +14.0% |
| R&D Expense | $74.4M | -10.2% | -14.0% |
| SG&A Expense | $72.3M | -9.1% | -2.1% |
| Operating Income | -$399K | +97.8% | +98.6% |
| Pre-tax Income | $14.8M | +815.2% | +243.5% |
| Income Tax | $2.0M | +281.0% | +53.8% |
| Net Income | $12.8M | +594.0% | +210.3% |
| EPS (Basic) | $0.13 | +533.3% | +218.2% |
| EPS (Diluted) | $0.12 | +500.0% | +209.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $994.7M | -9.1% | -5.1% |
| Accounts Receivable | $32.1M | -21.9% | +20.5% |
| Current Assets | $7.28B | -0.6% | +7.1% |
| Total Assets | $10.08B | -0.5% | +4.6% |
| Current Liabilities | $4.39B | -1.0% | +9.2% |
| Long-term Debt | $1.83B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $304.8M | — | — |
| Capital Expenditures | $3.0M | — | — |
| Investing Cash Flow | -$273.1M | — | — |
| Financing Cash Flow | -$221.5M | — | — |
| Free Cash Flow | $301.9M | — | — |
| +9.2% |
| Total Liabilities | $6.28B | -0.7% | +8.9% |
| Stockholders' Equity | $3.80B | -0.1% | -1.7% |